Flavonoids

NEWENTRY ; Severe acute respiratory syndrome-related coronavirus







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33251983 Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease. 2022 May 2
2 33236176 Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease. 2021 Aug 2
3 33363251 Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in COVID-19. 2021 1
4 33504301 Phenylbenzopyrone of Flavonoids as a Potential Scaffold to Prevent SARSCoV-2 Replication by Inhibiting its MPRO Main Protease. 2021 1
5 33618628 Investigation of the inhibitory activity of some dietary bioactive flavonoids against SARS-CoV-2 using molecular dynamics simulations and MM-PBSA calculations. 2021 Feb 23 2
6 33719855 Potentiality of Moringa oleifera against SARS-CoV-2: identified by a rational computer aided drug design method. 2021 Mar 15 1
7 33798836 Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study. 2021 Jun 1
8 34107799 Virtual screening, ADMET profiling, PASS prediction, and bioactivity studies of potential inhibitory roles of alkaloids, phytosterols, and flavonoids against COVID-19 main protease (Mpro). 2021 Jun 9 1
9 34208928 Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of Mpro and Its Antiviral Activity in Cells against SARS-CoV-2. 2021 Jun 30 1
10 34419736 Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis. 2021 Oct 1
11 34502340 Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease. 2021 Aug 30 2
12 34821532 Phytonutrient Inhibitors of SARS-CoV-2/NSP5-Encoded Main Protease (Mpro) Autocleavage Enzyme Critical for COVID-19 Pathogenesis. 2021 Nov 25 1
13 32768503 In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2. 2020 Nov 5 2
14 33027419 Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp). 2020 1
15 33320670 Proton-Coupled Conformational Activation of SARS Coronavirus Main Proteases and Opportunity for Designing Small-Molecule Broad-Spectrum Targeted Covalent Inhibitors. 2020 Dec 30 1